Breaking News
Top News
-
Here is Why Ocular Therapeutix (OCUL) is Highly Favored by Hedge Funds
-
Ultragenyx (RARE) Shares Positive Results From DTX301 Phase 3 Study
-
Biohaven (BHVN) Fuels Confidence With Encouraging Azetukalner Data
-
Hedge Funds View Inspire Medical (INSP) as One of the Best Small-Cap Healthcare Stocks
-
Sandisk and 6 Other Stocks Had Their Best Ever Quarter. These Had Their Worst.
-
Morning Bid: Finding the ‘off ramp’
-
Down 37%, This Cloud Stock Is Starting to Look Like a Screaming Buy
-
Nvidia Stock Is Ripe for Buying After Rare 2-Quarters Losing Streak. A History Lesson.
-
Resolute, NMC sign MoU for gold exploration in Guinea
-
Act now or lose it: The IRS warns $1.2 billion in overdue tax refunds will expire this month. Here’s how to claim yours
-
I want to quit at 62 — but I only have $375K in my accounts. How can I stretch my savings and retire now?
-
Crypto Fund Manager CoinShares Begins Trading on Nasdaq via SPAC Deal
-
Macy’s new AI tool drives 400% sales jump for the dividend stock
-
No Matter What Happens to the Market, These 5 Dividend Stocks Belong in Your Portfolio
-
5 Biotechs That Big Pharma Could Snap Up as Oncology M&A Heats Up
-
DA Davidson Maintains a Neutral Rating on Yext, Inc. (YEXT)
-
Nuvation Bio Inc. (NUVB) and Eisai Get EMA Validation for Taletrectinib
-
Lumen Technologies (LUMN) Announces Board Changes
-
Goldman Sachs Upgrades Nokia (NOK) to Neutral, Raises PT
-
First Thing: Trump launches tirade against Europe for not joining Iran war
2026-02-05



































